vs
Pediatrix Medical Group, Inc.（MD）与Voya Financial, Inc.（VOYA）财务数据对比。点击上方公司名可切换其他公司
Voya Financial, Inc.的季度营收约是Pediatrix Medical Group, Inc.的1.2倍（$603.0M vs $493.8M），Voya Financial, Inc.净利率更高（23.2% vs 6.8%，领先16.4%），Voya Financial, Inc.同比增速更快（7.5% vs -1.7%），过去两年Voya Financial, Inc.的营收复合增速更高（7.8% vs -0.1%）
Pediatrix Medical Group是美国领先的专科医疗服务提供商，核心业务覆盖母胎医学、新生儿科、儿科心脏病学等儿科亚专科领域，与美国各地医疗机构合作，为女性、新生儿及儿童提供循证专科医疗服务。
Voya Financial是总部位于美国纽约的金融服务机构，业务覆盖退休规划、投资管理及保险领域。其前身为ING集团美国运营子公司，2013年完成分拆并通过首次公开募股获得独立资金支持，2014年4月正式启用Voya Financial品牌，旗下前身机构最早在1970年代就已进入美国市场。
MD vs VOYA — 直观对比
营收规模更大
VOYA
是对方的1.2倍
$493.8M
营收增速更快
VOYA
高出9.2%
-1.7%
净利率更高
VOYA
高出16.4%
6.8%
两年增速更快
VOYA
近两年复合增速
-0.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $493.8M | $603.0M |
| 净利润 | $33.7M | $140.0M |
| 毛利率 | — | — |
| 营业利润率 | 9.9% | 28.0% |
| 净利率 | 6.8% | 23.2% |
| 营收同比 | -1.7% | 7.5% |
| 净利润同比 | 10.5% | 44.3% |
| 每股收益（稀释后） | $0.40 | $1.41 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收MDVOYA
| Q4 25 | $493.8M | $603.0M | ||
| Q3 25 | $492.9M | $572.0M | ||
| Q2 25 | $468.8M | $542.0M | ||
| Q1 25 | $458.4M | $538.0M | ||
| Q4 24 | $502.4M | $561.0M | ||
| Q3 24 | $511.2M | $542.0M | ||
| Q2 24 | $504.3M | $528.0M | ||
| Q1 24 | $495.1M | $519.0M |
净利润MDVOYA
| Q4 25 | $33.7M | $140.0M | ||
| Q3 25 | $71.7M | $192.0M | ||
| Q2 25 | $39.3M | $166.0M | ||
| Q1 25 | $20.7M | $156.0M | ||
| Q4 24 | $30.5M | $97.0M | ||
| Q3 24 | $19.4M | $114.0M | ||
| Q2 24 | $-153.0M | $205.0M | ||
| Q1 24 | $4.0M | $251.0M |
营业利润率MDVOYA
| Q4 25 | 9.9% | 28.0% | ||
| Q3 25 | 13.8% | 53.7% | ||
| Q2 25 | 12.8% | 34.7% | ||
| Q1 25 | 7.0% | 32.2% | ||
| Q4 24 | 7.8% | 21.4% | ||
| Q3 24 | 6.6% | 21.4% | ||
| Q2 24 | -31.3% | 52.3% | ||
| Q1 24 | 3.2% | 55.3% |
净利率MDVOYA
| Q4 25 | 6.8% | 23.2% | ||
| Q3 25 | 14.5% | 33.6% | ||
| Q2 25 | 8.4% | 30.6% | ||
| Q1 25 | 4.5% | 29.0% | ||
| Q4 24 | 6.1% | 17.3% | ||
| Q3 24 | 3.8% | 21.0% | ||
| Q2 24 | -30.3% | 38.8% | ||
| Q1 24 | 0.8% | 48.4% |
每股收益（稀释后）MDVOYA
| Q4 25 | $0.40 | $1.41 | ||
| Q3 25 | $0.84 | $1.80 | ||
| Q2 25 | $0.46 | $1.66 | ||
| Q1 25 | $0.24 | $1.42 | ||
| Q4 24 | $0.37 | $0.99 | ||
| Q3 24 | $0.23 | $0.98 | ||
| Q2 24 | $-1.84 | $1.96 | ||
| Q1 24 | $0.05 | $2.24 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $375.2M | — |
| 总债务越低越好 | $570.5M | $2.1B |
| 股东权益账面价值 | $865.9M | $5.0B |
| 总资产 | $2.2B | $178.9B |
| 负债/权益比越低杠杆越低 | 0.66× | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资MDVOYA
| Q4 25 | $375.2M | — | ||
| Q3 25 | $340.1M | — | ||
| Q2 25 | $224.7M | — | ||
| Q1 25 | $99.0M | — | ||
| Q4 24 | $229.9M | — | ||
| Q3 24 | $103.8M | — | ||
| Q2 24 | $19.4M | — | ||
| Q1 24 | $8.0M | — |
总债务MDVOYA
| Q4 25 | $570.5M | $2.1B | ||
| Q3 25 | $577.2M | $2.1B | ||
| Q2 25 | $583.9M | $2.1B | ||
| Q1 25 | $590.5M | $2.1B | ||
| Q4 24 | $597.1M | $2.5B | ||
| Q3 24 | — | $2.5B | ||
| Q2 24 | — | $2.1B | ||
| Q1 24 | — | $2.1B |
股东权益MDVOYA
| Q4 25 | $865.9M | $5.0B | ||
| Q3 25 | $890.7M | $5.0B | ||
| Q2 25 | $833.8M | $4.6B | ||
| Q1 25 | $789.2M | $4.4B | ||
| Q4 24 | $764.9M | $4.0B | ||
| Q3 24 | $732.5M | $4.7B | ||
| Q2 24 | $706.5M | $4.0B | ||
| Q1 24 | $856.2M | $4.2B |
总资产MDVOYA
| Q4 25 | $2.2B | $178.9B | ||
| Q3 25 | $2.2B | $177.4B | ||
| Q2 25 | $2.1B | $172.4B | ||
| Q1 25 | $2.0B | $163.9B | ||
| Q4 24 | $2.2B | $163.9B | ||
| Q3 24 | $2.1B | $166.9B | ||
| Q2 24 | $2.0B | $161.3B | ||
| Q1 24 | $2.2B | $161.6B |
负债/权益比MDVOYA
| Q4 25 | 0.66× | 0.42× | ||
| Q3 25 | 0.65× | 0.42× | ||
| Q2 25 | 0.70× | 0.45× | ||
| Q1 25 | 0.75× | 0.48× | ||
| Q4 24 | 0.78× | 0.62× | ||
| Q3 24 | — | 0.53× | ||
| Q2 24 | — | 0.52× | ||
| Q1 24 | — | 0.51× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $114.1M | $557.0M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | 3.39× | 3.98× |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流MDVOYA
| Q4 25 | $114.1M | $557.0M | ||
| Q3 25 | $137.3M | $168.0M | ||
| Q2 25 | $137.2M | $742.0M | ||
| Q1 25 | $-117.5M | $-179.0M | ||
| Q4 24 | $133.0M | $79.0M | ||
| Q3 24 | $91.8M | $719.0M | ||
| Q2 24 | $107.0M | $316.0M | ||
| Q1 24 | $-125.2M | $231.0M |
现金转化率MDVOYA
| Q4 25 | 3.39× | 3.98× | ||
| Q3 25 | 1.91× | 0.88× | ||
| Q2 25 | 3.49× | 4.47× | ||
| Q1 25 | -5.66× | -1.15× | ||
| Q4 24 | 4.36× | 0.81× | ||
| Q3 24 | 4.72× | 6.31× | ||
| Q2 24 | — | 1.54× | ||
| Q1 24 | -31.03× | 0.92× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
VOYA
| Other | $295.0M | 49% |
| Investment Management Segment | $274.0M | 45% |
| Distribution Fees Member | $34.0M | 6% |
